Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
May 3 RNA BofA starts Avidity at buy, cites upcoming clinical data
May 3 AGIO Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
May 3 AGIO Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2024 Earnings Call Transcript
May 3 BPMC Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcript
May 3 BPMC Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
May 3 AGIO Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
May 3 AGIO Agios Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 3 DCPH The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
May 3 BPMC Blueprint Medicines Corp (BPMC) (Q1 2024) Earnings Call Transcript Highlights: Surpassing ...
May 3 AGIO Agios Pharmaceuticals Inc (AGIO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
May 3 AGIO Q1 2024 Agios Pharmaceuticals Inc Earnings Call
May 3 BPMC Q1 2024 Blueprint Medicines Corp Earnings Call
May 2 ADMA Adma Biologics (ADMA) Rises Higher Than Market: Key Facts
May 2 AGIO Agios Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 2 AGIO Agios Pharmaceuticals, Inc. (AGIO) Q1 2024 Earnings Call Transcript
May 2 JANX Janux Therapeutics gains amid renewed takeover speculation
May 2 BPMC Blueprint Medicines Corporation (BPMC) Q1 2024 Earnings Call Transcript
May 2 BPMC Blueprint Medicines Corporation 2024 Q1 - Results - Earnings Call Presentation
May 2 DCPH Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
May 2 AGIO Agios Pharmaceuticals Reports Q1 2024 Earnings: Narrower Loss than Expected with Strong Revenue ...
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags